Cystic fibrosis liver disease progression in the era of elexacaftor-tezacaftor-ivacaftor. [PDF]
Mouliade C +12 more
europepmc +1 more source
Increased delay to lung transplantation for women candidates: gender-based disparity matters in the lung transplant trajectory. [PDF]
Tissot A +23 more
europepmc +1 more source
Kidney effects of triple CFTR modulator therapy in people with cystic fibrosis. [PDF]
Gabai P +7 more
europepmc +1 more source
Recommandations pour l’annonce du diagnostic de la mucoviscidose : rapport commenté de l'enquête dans les Centres et Réseaux de Compétences de la Mucoviscidose [PDF]
C. Langeard, G. Minguet
core +1 more source
Metagenomics Applied to the Respiratory Mycobiome in Cystic Fibrosis. [PDF]
Angebault C, Botterel F.
europepmc +1 more source
Impact of CFTR Modulators on Longitudinal Cystic Fibrosis Survival and Mortality: Review and Secondary Analysis. [PDF]
Rubin JL +5 more
europepmc +1 more source
Rinosinusites na prática clínica: guia de diagnóstico e tratamento [PDF]
Barros, E +7 more
core
ABCB4 disease-causing variants S242R, S346I, T437I and T1077M significantly impair its function and display differential sensitivity to potentiators. [PDF]
Madry C +13 more
europepmc +1 more source
Representation and quantification of module activity from omics data with rROMA. [PDF]
Najm M +7 more
europepmc +1 more source

